Skin manifestations in psoriatic and hs patients in treatment with biologicals during the covid‐19 pandemic

The Coronavirus Disease 2019 (COVID‐19) pandemic, a global public health emergency, has changed dermatology practice and daily routine in just under two years. Much has been written in the literature about COVID‐19‐associated skin manifestations. Nevertheless, much less has been written regarding skin manifestations in patients affected by severe immune‐mediated skin diseases, e.g., psoriasis and hidradenitis suppurativa, undergoing biological treatment during the COVID‐19 outbreak. Thus, the aim of this article is to provide the reader with an overview of the cutaneous manifestations during the COVID‐19 pandemic in this subset of patients.